IBT
VTRS icon

International Biotechnology Trust’s Viatris VTRS Stock Holding History

International Biotechnology Trust’s Portfolio VTRS Stock Details VTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-364,000
Closed -$3.1M – 69
2022
Q3 		$3.1M Buy
+364,000
New +$3.58M 0.99% 32
2017
Q3 		– Sell
-140,000
Closed -$5.43M – 64
2017
Q2 		$5.43M Buy
+140,000
New +$5.37M 2.06% 11

Other funds holding VTRS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

International Biotechnology Trust's VTRS Position: Q4 2022 in Review

International Biotechnology Trust sold out of Viatris (VTRS) in Q4 2022, closing a stake of 364,000 shares — an estimated $3.1M sold.

International Biotechnology Trust first reported a position in VTRS in Q2 2017 and held it in 2 quarters. The position peaked at $5.43M in Q2 2017. 1,015 funds tracked by Wall St. Rank hold VTRS as of Q4 2022.

  • International Biotechnology Trust reported no remaining Viatris position as of Q4 2022 after selling out during the quarter.
  • International Biotechnology Trust sold 364,000 Viatris shares in Q4 2022, an estimated $3.1M.
  • International Biotechnology Trust first reported a position in Viatris in Q2 2017 and held it in 2 quarters.
  • International Biotechnology Trust's Viatris position peaked at $5.43M in Q2 2017.
  • 1,015 funds tracked by Wall St. Rank held Viatris as of Q4 2022.

Based on International Biotechnology Trust's 13F filing for Q4 2022, filed 1 Feb 2023.